new version V2017

Orlistat weight-loss drugs
Description Results

Xenical - Alli - THLP - tetrahydrolipstatin - orlistat

pdf

Trial	Studied treatment	Control treatment	patients	ROB	Result	NCT
diabetes type 2
Heymsfield, 2000	orlistat	placebo		Low risk of bias	Negative
XENDOS (Chiasson), 2002	orlistat	placebo		Risk of bias	Negative
obesity and overweight
Hollander, 1998	Orlistat	placebo			-
Sjostrom, 1998	Orlistat	placebo			-
Davidson, 1999	Orlistat	placebo			-
Hill, 1999	Orlistat	placebo			-
Micic, 1999	Orlistat	placebo			-
Vidgren, 1999	Orlistat	placebo			-
Hauptman, 2000	Orlistat	placebo			-
Karhunen, 2000	Orlistat	placebo			-
Lindgarde, 2000	Orlistat	placebo			-
Rossner, 2000	Orlistat	placebo			-
Broom,, 2001	Orlistat	placebo			-
Deerochanawong,, 2001	Orlistat	placebo			-
Gotfredsen, 2001	Orlistat	placebo			-
Muls, 2001	Orlistat	placebo			-
Reaven, 2001	Orlistat	placebo			-
Rissanen, 2001	Orlistat	placebo			-
Shi Yi, 2001	Orlistat	placebo			-
Bakris, 2002	Orlistat	placebo			-
Broom, 2002	Orlistat	placebo			-
Hanefeld, 2002	Orlistat	placebo			-
Kelley, 2002	Orlistat	placebo			-
Miles, 2002	Orlistat	placebo			-
Naumov, 2002	Orlistat	placebo			-
Rosenfalck, 2002	Orlistat	placebo			-
Derosa, 2003	Orlistat	placebo			-
Halpern, 2003	Orlistat	placebo			-
Lucas, 2003	Orlistat	placebo			-
Krempf, 2005	Orlistat	placebo			-